Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination. - Suppr | 超能文献

Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination.

作者信息

Kelton J G, Warkentin T E

出版信息

Am J Clin Pathol. 1995 Dec;104(6):611-3. doi: 10.1093/ajcp/104.6.611.

DOI:10.1093/ajcp/104.6.611

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination.

Am J Clin Pathol. 1995 Dec;104(6):611-3. doi: 10.1093/ajcp/104.6.611.

2

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.

Am J Clin Pathol. 1995 Dec;104(6):648-54. doi: 10.1093/ajcp/104.6.648.

3

Laboratory diagnosis of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的实验室诊断

Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S21-7. doi: 10.1177/10760296990050s105.

4

Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.新型免疫分析法在诊断肝素诱导的血小板减少症中的有效性及在检测 IgG 抗体时提高特异性。

Thromb Haemost. 2010 Jan;103(1):145-50. doi: 10.1160/TH09-04-0253. Epub 2009 Sep 30.

5

Prospective Evaluation of a Rapid Functional Assay for Heparin-Induced Thrombocytopenia Diagnosis in Critically Ill Patients.危重症患者肝素诱导血小板减少症快速功能检测的前瞻性评估

Crit Care Med. 2019 Mar;47(3):353-359. doi: 10.1097/CCM.0000000000003574.

6

PF4 ENHANCED assay for the diagnosis of heparin-induced thrombocytopenia in complex medical and surgical patients.

Crit Care Med. 2007 Jul;35(7):1691-5. doi: 10.1097/01.CCM.0000268057.62578.3A.

7

Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay.使用酶联免疫吸附测定法对肝素依赖性抗体进行特异性定量以诊断肝素相关性血小板减少症。

Thromb Res. 1991 Jun 1;62(5):377-87. doi: 10.1016/0049-3848(91)90011-k.

8

Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?实验室检测用于诊断或排除肝素诱导的血小板减少症：命中还是错失？

Am J Hematol. 2018 Feb;93(2):308-314. doi: 10.1002/ajh.24979. Epub 2017 Dec 6.

9

Evaluating heparin-induced thrombocytopenia: the old and the new.评估肝素诱导的血小板减少症：旧的和新的。

Semin Thromb Hemost. 2012 Mar;38(2):135-43. doi: 10.1055/s-0032-1301411. Epub 2012 Feb 8.

10

A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.在心胸外科重症监护病房的患者中，采用临床和实验室相结合的方法诊断肝素诱导的血小板减少症。

Anesth Analg. 2011 Oct;113(4):697-702. doi: 10.1213/ANE.0b013e3182297031. Epub 2011 Jul 25.

引用本文的文献

1

Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.维生素K拮抗剂与低分子量肝素用于有症状静脉血栓栓塞症的长期治疗比较

Cochrane Database Syst Rev. 2017 Jul 24;7(7):CD002001. doi: 10.1002/14651858.CD002001.pub3.

2

Catastrophic antiphospholipid syndrome.

Curr Rheumatol Rep. 2003 Oct;5(5):395-400. doi: 10.1007/s11926-003-0031-7.

3

Prevention and treatment of venous thromboembolism.静脉血栓栓塞症的预防与治疗。

Drugs. 1996 Jul;52(1):71-92. doi: 10.2165/00003495-199652010-00006.